Windham Life Sciences Partners IV, L.P. — Form D/A
Windham Life Sciences Partners IV, L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2024-11-15. The offering totals $150.0M, of which $19.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-11-15
- Form: D/A
- Accession: 0001999637-24-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $150.0M
- Amount sold: $19.5M
- Remaining: $130.5M
- Minimum investment: $1
- Investors: 32
- Date of first sale: 2023-10-27
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-496484
Issuer
- Name: Windham Life Sciences Partners IV, L.P.
- CIK: 0001999637
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 500 FIFTH AVENUE, NEW YORK, NY, 10110
- Phone: (917) 848-3935
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| - E Windham Life Sciences Partners General Partner IV, LLC | Director | New York, NY |
| Adam E Fine | Executive Officer | New York, NY |
| Adam E Fine | Promoter | New York, NY |
| Adam E Windham Life Sciences Partners General Partner IV, LLC | Promoter | New York, NY |
Other filings by this issuer (3)
More